The purpose of this study is to determine if the 2 gram single dose of metronidazole is as
effective as the 7 day 500 mg BID dose for treatment of Trichomonas vaginalis (TV) among
HIV-infected women.
Phase:
Phase 4
Details
Lead Sponsor:
Tulane University Health Sciences Center
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)